TITLE

Weighing benefits and risks of drug to treat obesity

PUB. DATE
March 1997
SOURCE
CMAJ: Canadian Medical Association Journal;03/15/97, Vol. 156 Issue 6, p768
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
22950428

 

Related Articles

  • The Skinny on Weight-Loss Surgery. Firment, Lynda; Morrison, Sarah // AAOHN Journal;Sep2006, Vol. 54 Issue 9, p405 

    This article discusses various treatments and surgery for obese employees. Obesity is a major health problem in the U.S. Approximately 65% of U.S. population are considered obese. Drug options for weigh management include Orlistat and Sibutramine. The benefits of the Stages of Change model,...

  • At what point in the treatment of infectious uveitis do you consider weighing the risks and benefits of corticosteroids? Quan Dong Nguyen; Veritti, Daniele // Ocular Surgery News;10/25/2015, Vol. 33 Issue 20, p11 

    The article provides an answer to a question on what point in treating infectious uveitis have been considered on weighing the risks and benefits of corticosteroids.

  • Optimal management of pediatric patients. Petrou, Ilya // Dermatology Times;Aug2015 Supplement Dermatology Times, Vol. 36, p6 

    The article discusses the treatment and management of psoriasis in pediatric patients. Topics discussed include how treatment must be individualized and specifically tailored for each patient with risks and benefits of potential treatments weighed against the risks of undertreated disease,...

  • Obesity treatment poses a variety of challenges. Alper, Philip R. // Primary Care Weekly;10/28/96, Vol. 2 Issue 42, p5 

    Makes observations concerning obesity in the United States. Percentage of Americans who are above their ideal weight; Obesity as a disease; Prescription of addictive drugs to patients seeking to lose weight; Benefits of traditional psychotherapy in treating obesity.

  • From chlorpromazine to clozapine--antipsychotic adverse effects and the clinician's dilemma. Abidi, Sabina; Bhaskara, Sreenivasa M. // Canadian Journal of Psychiatry;Dec2003, Vol. 48 Issue 11, p749 

    The pharmacotherapy of schizophrenia remains an ongoing challenge for researchers and clinicians alike. Current medications remain suboptimal to effectively treat this illness despite the recent surge of what are considered to be better antipsychotics: the atypicals. The atypicals cause fewer...

  • Pharmacotherapy and surgery in the treatment of obesity: evaluating risks and bene. Chee Fang Sum // Asia Pacific Journal of Clinical Nutrition;Dec2002 Supplement, Vol. 11, p722 

    Assesses the risks and disadvantages of using pharmacotherapy and surgery in treating obesity. Insufficiency of evidence that will support a drug-based approach to the treatment of obesity; Discussion of the additional health risks that a surgical approach can cause.

  • Safety of antipsychotic drugs for pregnant and breastfeeding women with non-affective psychosis. Howard, Louise; Webb, Roger; Abel, Kathryn // BMJ: British Medical Journal (International Edition);10/23/2004, Vol. 329 Issue 7472, p933 

    Focuses on the fertility of women with non-affective psychotic disorders. Lower fertility of women with non-affective psychoses due to hyperprolactinaemia caused by antipsychotic drugs; Possibility that atypical drugs such as clozapine and olanzapine, which do not cause hyperprolactinaemia, may...

  • BBC1.  // Mail on Sunday;4/ 6/2014, p54 

    Casualty 8.40pm Weighed down with problems: Lily and Jeff treat obese patient Jim

  • Filling the Void. Vash, Peter // JAMA: Journal of the American Medical Association;4/4/2012, Vol. 307 Issue 13, p1381 

    A personal narrative is presented which explores the author's experience of treating Paula's obesity who weighed more than 325 pounds.

  • Bariatric surgery. Arterburn, David // BMJ: British Medical Journal (International Edition);9/6/2008, Vol. 337 Issue 7669, p528 

    The author reflects on bariatric surgery. He suggests that bariatric surgery can reduce weight and improve long term survival of obese people but also carries risks. He argues that individual patients must weigh the benefits of the surgery against the short term risks of death, complications and...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics